Physician profile
Heather Avelar
NPI 1720253115
$2,035.94
in general payments reported to CMS, 2019-2025
18 companies · $20.66 in 2025
The $20.66 reported for 2025 was less than what a typical Geriatric Psychiatry provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253 · 2022: $562 · 2023: $866 · 2024: $335 · 2025: $20.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216 · Education: $5.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.99 |
| Education | $5.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $429.16 | 2022-2024 | Rexulti, Abilify Maintena, Nuedexta |
| Janssen Pharmaceuticals, INC | $276.60 | 2021-2024 | Invega Trinza, Invega Sustenna |
| Takeda Pharmaceuticals U.S.A., INC. | $199.49 | 2021-2024 | Trintellix |
| Sunovion Pharmaceuticals INC. | $175.46 | 2022 | |
| Corium, LLC | $155.55 | 2022-2024 | Azstarys |
| Neurocrine Biosciences, INC. | $153.17 | 2022-2023 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $150.88 | 2021-2024 | Austedo Xr |
| Abbvie INC. | $103.62 | 2023-2025 | Vraylar |
| Indivior INC. | $81.99 | 2022-2023 | Perseris |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $79.19 | 2022-2023 | |
| Lundbeck LLC | $78.84 | 2022-2024 | Rexulti |
| Alkermes, INC. | $47.07 | 2023-2024 | Aristada, Lybalvi |
| Neuronetics, INC. | $23.74 | 2023 | Neurostar Tms Therapy System |
| Almatica Pharma LLC | $19.71 | 2022 | |
| Insulet Corporation | $16.92 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $15.81 | 2024 | Fanapt |
| Sage Therapeutics, LLC | $15.74 | 2024 | |
| Axsome Therapeutics, INC. | $13.00 | 2023 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Avelar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.